Netherlands· NL-25000f2d6cb6

Dipentum 250 mg, harde capsules

A olsalazine product containing olsalazine dinatrium, registered in Netherlands by Atnahs Pharma Netherlands B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC A07EC03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about olsalazine dinatriumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Olsalazine is registered in 11 of 19 countries.

Countries holding a registration under ATC A07EC03 (olsalazine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
5 of them publish a price we can compare per daily dose

Search olsalazine products by name

Olsalazine · ATC A07EC03

11 / 19 countries

Canada
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of olsalazine costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Olsalazine · price per daily dose (1 g)

USD · FX 28 Sept 2026

FR France$1.44

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: OLSALAZINE DINATRIUM
Manufacturer: Atnahs Pharma Netherlands B.V.
Country: Netherlands (NL)
ATC code: A07EC03
ATC class: Olsalazine
Defined daily dose: 1 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
11790

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

110 interactions on record for olsalazine.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check olsalazine against other medicines How interaction checks work

Olsalazine · interactions on record

110 records

15 severe
93 moderate
2 minor

Most severe, free to view

CidofovirJ05AB12severe
Humane Immunglobuline, unspezifisch, extravaskulärJ06BA01severe
Humane Immunglobuline, unspezifisch, intravaskulärJ06BA02severe
SirolimusL01EG04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Olsalazine in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olsalazine products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

Germany · Dipentum
Denmark · Dipentum
Finland · Dipentum
France · Dipentum
United Kingdom (Northern Ireland) · Olsalazine Sodium Atnahs Pharma Uk
Ireland · Dipentum
Iceland · Dipentum
Norway · Dipentum
Sweden · Dipentum

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/dc12929e-1b6f-426d-b8e6-009f91644b02
GET /v1/drugs/dc12929e-1b6f-426d-b8e6-009f91644b02?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h11790_smpc.pdf",
  "strength": null,
  "atc_label": "Olsalazine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg11790",
  "excipients": [
    "AMMONIA (E 527)",
    "CARAMEL (E 150a)",
    "GELATINE (E 441)",
    "IJZEROXIDE ZWART (E 172)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
    "TITAANDIOXIDE (E 171)",
    "ZWARTE INKT"
  ],
  "substances": [
    "OLSALAZINE DINATRIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h11790.pdf",
  "authorised_at": "1988/02/23",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "11790",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about olsalazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console